Research suggests that regular use of certain types of commonly-prescribed drugs could significantly increase the risk of ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other ...

THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the regulator. Charities and scientists said patients are being left behind ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

In summary, while there is no guaranteed way to prevent dementia, taking blood pressure medication as prescribed may help ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...